Hypolipidaemic and antiatherosclerotic effects of plumbagin in rabbits
- PMID: 1917004
Hypolipidaemic and antiatherosclerotic effects of plumbagin in rabbits
Abstract
Plumbagin (2-methyl-5-hydroxy, 1:4 naphthoquinone) isolated from the roots of Plumbago zeylanica when administered to hyperlipidaemic rabbits, reduced serum cholesterol and LDL-Chol. by 53 to 86 percent and 61 to 91 percent respectively. It lowered cholesterol/phospholipid ratio by 45.8 percent and elevates the decreased HDL-Chol significantly. Further, Plumbagin treatment prevented the accumulation of cholesterol and triglycerides in liver and aorta and regressed atheromatous plaques of thoracic and abdominal aorta. Plumbagin treated hyperlipidaemic subjects excreted more fecal cholesterol and phospholipids. In conclusion-Plumbagin feeding brings about a definite regression of atheroma and prevents the accumulation of cholesterol and triglycerides in liver and aorta.
Similar articles
-
Prevention of hypercholesterolemia and atherosclerosis in rabbits after supplementation of Myristica fragrans seed extract.Indian J Physiol Pharmacol. 1995 Oct;39(4):407-10. Indian J Physiol Pharmacol. 1995. PMID: 8582756
-
Hypolipidaemic efficacy of Capparis decidua fruit and shoot extracts in cholesterol fed rabbits.Indian J Exp Biol. 2005 Oct;43(10):863-6. Indian J Exp Biol. 2005. PMID: 16235718
-
Hypocholesterolemic activity of nut shell extract of Semecarpus anacardium (Bhilawa) in cholesterol fed rabbits.Indian J Exp Biol. 1995 Jun;33(6):444-8. Indian J Exp Biol. 1995. PMID: 7590951
-
Hypolipidaemic and antioxidant effect of Enicostemma littorale Blume aqueous extract in cholesterol fed rats.J Ethnopharmacol. 2005 Oct 3;101(1-3):277-82. doi: 10.1016/j.jep.2005.05.007. J Ethnopharmacol. 2005. PMID: 15955647
-
Perspectives on medicinal properties of plumbagin and its analogs.Med Res Rev. 2012 Nov;32(6):1131-58. doi: 10.1002/med.20235. Epub 2010 Nov 9. Med Res Rev. 2012. PMID: 23059762 Review.
Cited by
-
Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production.Oncotarget. 2016 Dec 13;7(50):82864-82875. doi: 10.18632/oncotarget.12655. Oncotarget. 2016. PMID: 27756878 Free PMC article.
-
Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.Acta Pharmacol Sin. 2015 Sep;36(9):1085-98. doi: 10.1038/aps.2015.42. Epub 2015 Aug 3. Acta Pharmacol Sin. 2015. PMID: 26235741 Free PMC article.
-
Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.Acta Pharmacol Sin. 2014 Jan;35(1):124-34. doi: 10.1038/aps.2013.152. Acta Pharmacol Sin. 2014. PMID: 24384612 Free PMC article.
-
Current status of NADPH oxidase research in cardiovascular pharmacology.Vasc Health Risk Manag. 2013;9:401-28. doi: 10.2147/VHRM.S33053. Epub 2013 Jul 25. Vasc Health Risk Manag. 2013. PMID: 23983473 Free PMC article. Review.
-
Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis.Int J Oncol. 2014 Nov;45(5):1913-20. doi: 10.3892/ijo.2014.2592. Epub 2014 Aug 8. Int J Oncol. 2014. PMID: 25109615 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical